Newsfeeds - Spark Newswire

1 minute read

Sera Prognostics Q1 EPS $(0.40) Misses $(0.37) Estimate, Sales $38.00K Miss $50.00K Estimate

Today, 3:55 PM

Sera Prognostics (NASDAQ:SERA) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.37) by 8.11 percent. This is a 88.73 percent increase over losses of $(3.55) per share from

SERA

20 minute read

Earnings Scheduled For May 10, 2022

By Benzinga Insights

Today, 3:55 PM

Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.

ABCL

6 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For April 27, 2022

By Benzinga Insights

Today, 3:55 PM

ACC

2 minute read

Earnings

Looking Into Sera Prognostics’s Return On Capital Employed

By Benzinga Insights

Today, 3:55 PM

Benzinga Pro data, Sera Prognostics (NASDAQ:SERA) reported Q4 sales of $26.00 thousand. Earnings fell to a loss of $12.48 million, resulting in a 26.63% decrease from last quarter.

SERA

1 minute read

Sera Prognostics Q4 EPS $(0.41) Misses $(0.29) Estimate, Sales $26.00K Miss $130.00K Estimate

By Bill Haddad

Today, 3:55 PM

Sera Prognostics (NASDAQ:SERA) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.29) by 41.38 percent. The company reported quarterly sales of $26.00 thousand which missed

SERA

5 minute read

Earnings Scheduled For March 29, 2022

By Benzinga Insights

Today, 3:55 PM

Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.

AMPE

5 minute read

75 Biggest Movers From Yesterday

By Lisa Levin

Today, 3:55 PM

Gainers NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) shares jumped 299.4% to close at $6.23 on Monday as the company received clearance from the FDA to initiate a pharmacokinetic study of PrimeC in healthy adult subjects.